US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

40.54

+0.41201.03%

Volume:3K

Turnover:134.96K

Market Cap:203.93M

PE:- -

High:40.79

Open:40.29

Low:40.17

Close:40.13

52wk High:47.00

52wk Low:29.28

Shares:5.03M

Float Shares:5.03M

Volume Ratio:0.43

T/O Rate:0.07%

Dividend:0.02

Dividend Rate:0.05%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Roche unit launches LightMix Newborn TREC/SMN1/HBB kit

Roche’s Genentech announces FDA approves NDA for fenebrutinib

Roche's BTK Inhibitor Filing Accepted for Review

Junshi Bio (01877) Surges Over 4% on Strategic Partnership with Meijie Medical to Explore "Multimodal Drug-Device Combination" in Cancer Treatment

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS

Roche's New Breast-Cancer Drug Supports Midterm Growth Outlook

Roche Shows New Research-and-Development Approach is Bearing Fruit

Roche Dashes Hopes of Guidance Upgrade

Roche Needs Next Drug Launches to Go Smoothly

Roche Signals it is Too Soon to Know if AI Improves Trial Success Rates

Roche Seems Increasingly Confident in Obesity Portfolio

Eli Lilly Reports Zepbound Showed 4.5% Greater Weight Loss Than Novo Nordisk's Wegovy HD

MT Newswires Live

Eli Lilly’s Zepbound shows improved weight loss vs. Wegovy in new analysis

Eli Lilly - Zepbound 10 Mg and 15 Mg Show Comparable Adverse Event Discontinuation Rates to Wegovy Hd

THOMSON REUTERS

Eli Lilly - Zepbound 15 Mg Shows 4.5% Greater Weight Loss than Wegovy Hd in Adults with Obesity

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/stock/CANC/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CANC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","market":"US","secType":"STK","nameCN":"TEMA ONCOLOGY ETF","latestPrice":40.542,"timestamp":1791557119660,"preClose":40.13,"halted":0,"volume":3339,"delay":0,"changeRate":0.0102666334413157,"floatShares":5030000,"shares":5030000,"eps":0,"marketStatus":"Trading","change":0.412,"latestTime":"10-09 10:47:49 EDT","open":40.29,"high":40.785,"low":40.17,"amount":134963.762346,"amplitude":0.015325,"askPrice":40.46,"askSize":700,"bidPrice":40.37,"bidSize":700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1692158400000,"exchange":"NASDAQ","adjPreClose":40.13,"sharesOutstanding":4310000,"nav":40.45,"aum":203463500,"dividendRate":0.000483,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":40.13,"preClose":40.13,"latestTime":"19:30 EDT","volume":12,"amount":481.56,"timestamp":1791502203524,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.43293},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","floatShares":5030000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.43293,"shares":5030000,"dividePrice":0.0196,"high":40.785,"amplitude":0.015325,"preClose":40.13,"low":40.17,"week52Low":29.28,"pbRate":"--","week52High":47,"institutionHeld":0,"latestPrice":40.542,"eps":0,"divideRate":0.000483,"volume":3339,"delay":0,"ttmEps":0,"open":40.29,"prevYearClose":34.7203,"prevWeekClose":40.99,"prevMonthClose":42.01,"prevQuarterClose":42.01,"fiveDayClose":40.99,"twentyDayClose":41.5285,"sixtyDayClose":40.5053},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CANC\",params:#limit:5,,,undefined,":[{"date":"2025-12-10","symbol":"CANC","amount":0.0195905,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-11","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-11"},{"date":"2024-12-11","symbol":"CANC","amount":0.72827,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-11","defaultRemindTime":1733927400000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-12-11","currency":"USD","dateTimestamp":1733893200000,"payDate":"2024-12-12"},{"date":"2023-12-13","symbol":"CANC","amount":0.149112,"announcedDate":"2023-12-12","type":"dividend","market":"US","newRecordDate":"2023-12-14","defaultRemindTime":1702477800000,"name":"TEMA ONCOLOGY ETF","recordDate":"2023-12-15","payableDate":"2023-12-14","currency":"USD","dateTimestamp":1702443600000,"payDate":"2023-12-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CANC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-13","recordDate":"2023-12-14","paymentDate":"2023-12-15","value":0.149112,"currency":"USD"},{"executeDate":"2024-12-11","recordDate":"2024-12-11","paymentDate":"2024-12-12","value":0.72827,"currency":"USD"},{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-11","value":0.0195905,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CANC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CANC\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671920812","title":"Roche unit launches LightMix Newborn TREC/SMN1/HBB kit","url":"https://stock-news.laohu8.com/highlight/detail?id=2671920812","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671920812?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762124,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix Newborn TREC/SMN1/HBB kit, an in vitro diagn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-unit-launches-lightmix-newborn-trec-smn1-hbb-kit-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-unit-launches-lightmix-newborn-trec-smn1-hbb-kit-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["03165","HBB","BK4007","HRTS","RHHBY","CANC","BK4191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220846","title":"Roche’s Genentech announces FDA approves NDA for fenebrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220846","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220846?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:50","pubTimestamp":1790761812,"startTime":"0","endTime":"0","summary":"Genentech, a member of the Roche (RHHBY) Group, announced that the U.S. FDA has accepted the company’s NDA under priority review for fenebrutinib, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roches-genentech-announces-fda-approves-nda-for-fenebrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roches-genentech-announces-fda-approves-nda-for-fenebrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","CANC","LABU","HRTS","RHHBY","03165","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136126067","title":"Roche's BTK Inhibitor Filing Accepted for Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1136126067","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136126067?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755216,"startTime":"0","endTime":"0","summary":"Roche Holding Ltd (RHHBY.US) announced on September 30 that the U.S. FDA has accepted its New Drug Application (NDA) for the non-covalent BTK inhibitor fenebrutinib and granted it priority review for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTS","03165","IPOS","RHHBY","BK4007","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195660530","title":"Junshi Bio (01877) Surges Over 4% on Strategic Partnership with Meijie Medical to Explore \"Multimodal Drug-Device Combination\" in Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1195660530","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195660530?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:50","pubTimestamp":1790736617,"startTime":"0","endTime":"0","summary":"Junshi Bio (01877) rose more than 4%, reaching 4.03% as of press time, at HK$19.09, with a turnover of HK$23.2684 million.On the news front, according to Junshi Bio's official WeChat account, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","KCAI","BK4588","LU0329678337.USD","01877","BK1161","159891","BK1515","CANC","LU0329678170.USD","LU0737861772.HKD","BK1209","LU2488822045.USD","VXUS","06078","BK1583","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224004","title":"Eli Lilly reports results from TRIUMPH-2 Phase 3 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224004","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224004?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:10","pubTimestamp":1790719814,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) and Company announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an invest...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BK4W5M84.HKD","LU1064131342.USD","LU1057294990.SGD","LU0345770993.USD","LU2456880835.USD","LU0943347566.SGD","LU0354030438.USD","LU0820561909.HKD","LU0234572021.USD","SG9999018865.SGD","GDOC","LU0114720955.EUR","LU0964807845.USD","LU2023250330.USD","LU2746668974.SGD","LU2236285917.USD","LU2361045086.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0094547139.USD","BK4007","LU0456855351.SGD","SGXZ51526630.SGD","ILDR","LU1868837300.USD","LU0672654240.SGD","LLYZ","LU0466842654.USD","LU2213496289.HKD","LU2361044949.HKD","LU0320765992.SGD","LU2746668461.USD","GB00BDT5M118.USD","LU1093756168.USD","SG9999015952.SGD","BK4581","SG9999018857.SGD","WDNA","LU2471134523.USD","LLY","LU2552382132.HKD","LU1035775433.USD","BK4534","IXJ","LU2361044865.SGD","SG9999014914.USD","LU1061106388.HKD","OZEM","LU2552382215.SGD","LU0708995401.HKD","LU1974910355.USD","IE0005OL40V9.USD","BK4533","LU0266013472.USD","LU0882574055.USD","LU2750360641.GBP","HRTS","LU2168564065.EUR","LU1989771016.USD","SG9999014880.SGD","CURE","LU1868836591.USD","LU1548497426.USD","IE00BFSS8Q28.SGD","LU0096364046.USD","LU0198837287.USD","IE00BKPKM429.USD","LU0385154629.USD","LU2063271972.USD","LU0689472784.USD","LU2089284900.SGD","IE00BN29S564.USD","XLV","LU1291159041.SGD","IE00BFSS7M15.SGD","LU0256863902.USD","AGNG","IE0001KFT4U8.USD","LU2168563687.JPY","LU2756315318.SGD","IE00B1XK9C88.USD","SG9999001176.SGD","IE00BK4W5L77.USD","ELIS","IE0004445239.USD","LU0061475181.USD","BK4588","LU1868836757.USD","LU2023251221.USD","SGXZ81514606.USD","LU0058720904.USD","TMED","LU0353189680.USD","LU2271345857.HKD","LU0225283273.USD","LU0320765059.SGD","SG9999017495.SGD","LU0432979614.USD","LU2461242641.AUD","LU2896262040.SGD","BK4599","LU1551013342.USD","LU1280957306.USD","LU0787776722.HKD","LU0353189763.USD","LU0106261372.USD","LU1629891620.HKD","LU2237438978.USD","IE00BWXC8680.SGD","LU0323591593.USD","IE00B7KXQ091.USD","LU1814569148.SGD","LU1712237335.SGD","SG9999014906.USD","IE00BJJMRY28.SGD","IYH","LU0471298694.HKD","LU2750360997.AUD","LU0823434740.USD","LU0640476718.USD","LU1127390331.HKD","LU2089283258.USD","RXL","SGXZ57979304.SGD","LU0316494557.USD","LU2168564222.USD","LU2237443622.USD","SGXZ31699556.SGD","LU2491050071.SGD","TRUH","LU0109394709.USD","LU2264538146.SGD","LU0210536198.USD","LU0354030511.USD","LU1868836914.USD","LU2089984988.USD","LU2357305700.SGD","LU2462157665.USD","CANC","LU0882574139.USD","LU1979441026.SGD","LU2211815571.USD","IE00B4JS1V06.HKD","IE0004445015.USD","LU1093756325.SGD","LLYX","IE00B775H168.HKD","IE00BKDWB100.SGD","SGXZ99366536.SGD","ELIL","LU1023059063.AUD","LU1983299246.USD","LU1623119135.USD","SG9999001176.USD","SG9999014898.SGD","LU1366192091.USD","LU0889565916.HKD","LU0158827781.USD","LU0174119429.USD","FTXH","LU1069344957.HKD","LU2112291526.USD","MEDI","SG9999013999.USD","LU2756315664.SGD","LU2111349929.HKD","LU0203201768.USD","BK4585","LU0256863811.USD","LU1232071149.USD","LU2491049909.HKD","LU0097036916.USD","LU2471134796.USD","LU0823434583.USD","PPH","LU0109391861.USD","IE00BJLML261.HKD","LU0345770308.USD","LU2237443465.HKD","LU2237443895.HKD","LU0820561818.USD","LU2237443978.SGD","LU1323610961.USD","SG9999015978.USD","IE0002141913.USD","LU2106854487.HKD","LU0823416689.USD","IHE","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU2087625088.SGD","LU2168564495.EUR","MEDX","LU2028103732.USD","LU0203202063.USD","LU0683600562.USD","LLII","LU0158827948.USD","LU2491050154.USD","LU2602419157.SGD","LU1917777945.USD","LU2417539215.USD","LU1720051017.SGD","LU0820562030.AUD","LU1267930730.SGD","JDOC","IE00BJT1NW94.SGD","LU2237443382.USD","LU2265009873.SGD","THNR","LU2168564149.EUR","LU2552382058.USD","LU0122379950.USD","LU1145028129.USD","VHT","LU2237443549.SGD","PJP","LU0133085943.USD","LU0238689110.USD","LU1691799644.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU1988902786.USD","LU0289739699.SGD","LU2324357040.USD","SG9999015945.SGD","LU1551013425.SGD","IE0009355771.USD","LU2023250504.SGD","LU2108987350.USD","LU2471134879.HKD","IE00B1BXHZ80.USD","FHLC","IE00B4R5TH58.HKD","LU0079474960.USD","LU1804176565.USD","LU1868837136.USD","LU0006306889.USD","LU2462591350.SGD","MHIP","SG9999015986.USD","LU1720051108.HKD","LU2471134952.CNY","BK4516","IE00BFTCPJ56.SGD","LU2360106947.USD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671402792","title":"Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671402792","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671402792?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:06","pubTimestamp":1790719599,"startTime":"0","endTime":"0","summary":"Lilly's experimental drug cuts weight by 21% in diabetes trialSept 29 (Reuters)-Eli LillyLLY.Nsaid on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L216:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","IE0004445239.USD","IE0005OL40V9.USD","SG9999014880.SGD","LU0786609619.USD","ELIL","LU1868836591.USD","ILDR","LU0058720904.USD","LU0353189680.USD","LU0787776722.HKD","LU1280957306.USD","LU1366192091.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU2168564149.EUR","BK4581","LU0889565916.HKD","GDOC","LU2028103732.USD","TRUH","LU1804176565.USD","LU2237438978.USD","LU0203202063.USD","LU0174119429.USD","LU0823416689.USD","LU0289739699.SGD","IE00B775H168.HKD","LU2236285917.USD","LU2361045086.USD","IE00BJJMRY28.SGD","LU2491050071.SGD","SG9999014906.USD","BK4533","SGXZ51526630.SGD","LU1057294990.SGD","LU0882574055.USD","LU2417539215.USD","LU0471298694.HKD","LU2108987350.USD","LU2756315318.SGD","LU2089283258.USD","LU2361044949.HKD","LU2471134952.CNY","LU0689472784.USD","IE00BWXC8680.SGD","BK4516","SG9999017495.SGD","BK4534","LU2168564065.EUR","SG9999015978.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU2023250504.SGD","LU1623119135.USD","SG9999001176.SGD","LU1127390331.HKD","LU1232071149.USD","LU0708995401.HKD","LU2552382215.SGD","LU1988902786.USD","LU2265009873.SGD","LU2361044865.SGD","LU2112291526.USD","LU0109394709.USD","LU0354030511.USD","LU1267930730.SGD","LU0061475181.USD","MEDX","LU0096364046.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2746668461.USD","LU1989771016.USD","LU1548497426.USD","LU0225283273.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU0079474960.USD","LU1720051017.SGD","LU2461242641.AUD","IXJ","IE0009355771.USD","LU0158827948.USD","VHT","LU0256863902.USD","FHLC","FTXH","LU0672654240.SGD","LU0097036916.USD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2360106947.USD","BK4007","LU0114720955.EUR","GB00BDT5M118.USD","LU0133085943.USD","LU0345770308.USD","LU2168564222.USD","LU2462157665.USD","LU2750360997.AUD","LU0106261372.USD","LU0266013472.USD","LU2111349929.HKD","SG9999013999.USD","LU1023059063.AUD","SG9999018865.SGD","LU2552382132.HKD","LU0234572021.USD","LU2462591350.SGD","IE00BFTCPJ56.SGD","OZEM","LU2168563687.JPY","LU2237443382.USD","SG9999014898.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU0964807845.USD","LU1093756325.SGD","LU2264538146.SGD","LU0210536198.USD","PPH","LU2023250330.USD","IHE","LU2237443465.HKD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","JDOC","AGNG","IE0001KFT4U8.USD","LU2468319806.SGD","LU0683600562.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2089984988.USD","LU0256863811.USD","LU1868837300.USD","LU2168564495.EUR","IE00BK4W5L77.USD","SG9999014914.USD","LU0820561909.HKD","LU2491049909.HKD","LU1868836914.USD","LU2211815571.USD","LU2213496289.HKD","LU1323610961.USD","SG9999018857.SGD","SGXZ57979304.SGD","LLYZ","LU0417517546.SGD","CANC","THNR","SG9999015945.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","LU2471134796.USD","CURE","LU1629891620.HKD","LU2602419157.SGD","BK4599","LU0323591593.USD","MEDI","LLII","LU1974910355.USD","LU1064131342.USD","LU1035775433.USD","LU1712237335.SGD","LU0823434583.USD","IYH","LU0320765992.SGD","LU0432979614.USD","IE00BKDWB100.SGD","LU2357305700.SGD","ELIS","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","LLY","LU1814569148.SGD","LU2750360641.GBP","LU1691799644.USD","LU2237443895.HKD","WDNA","PJP","LU0122379950.USD","LU0471298777.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0385154629.USD","LU0353189763.USD","LU0456855351.SGD","LU2456880835.USD","BK4585","LU1145028129.USD","LU1868837136.USD","LU1551013425.SGD","LU1093756168.USD","LU2324357040.USD","LU2552382058.USD","LU2237443549.SGD","HRTS","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU1551013342.USD","LU0238689110.USD","LU2491050154.USD","BK4588","LU0109391861.USD","LU1979441026.SGD","LU0198837287.USD","LU2106854487.HKD","IE0004445015.USD","LU0006306889.USD","LU0820561818.USD","LU0820562030.AUD","IE00BN29S564.USD","LU1917777945.USD","MHIP","LU0158827781.USD","LU0640476718.USD","LU2237443978.SGD","LU0354030438.USD","LU0882574139.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE00BK4W5M84.HKD","XLV","LU0316494557.USD","LLYX","LU2237443622.USD","SG9999015986.USD","LU2063271972.USD","LU0345770993.USD","LU0094547139.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671446240","title":"Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671446240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671446240?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237443549.SGD","GDOC","JDOC","LU0234572021.USD","LU0354030511.USD","LU2089284900.SGD","LU2168564065.EUR","LU0323591593.USD","LU2213496289.HKD","LU2750360997.AUD","BK4007","LU0114720955.EUR","SGXZ51526630.SGD","SG9999014898.SGD","LU0203201768.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","IE00BJJMRX11.SGD","LU0456855351.SGD","LU0683600562.USD","LU2023250330.USD","SG9999014906.USD","IE0009355771.USD","LU2271345857.HKD","LU1280957306.USD","LU2237443465.HKD","LU2471134879.HKD","MEDI","IE00B7KXQ091.USD","GB00BDT5M118.USD","BK4581","LU0320765059.SGD","LU1035775433.USD","LU2746668461.USD","LU2168564495.EUR","IE00BK4W5M84.HKD","LU2236285917.USD","LU2471134952.CNY","LU2108987350.USD","LU0096364046.USD","LU0689472784.USD","LU0820561909.HKD","LU2087625088.SGD","IE0004445015.USD","LU0094547139.USD","LU2211815571.USD","LU2456880835.USD","BK4516","LU1691799644.USD","LU2112291526.USD","LU1366192091.USD","SG9999018865.SGD","LU2491049909.HKD","LU0385154629.USD","LU0345770308.USD","LU1548497426.USD","SG9999013999.USD","LU0316494557.USD","LU1069344957.HKD","LU1629891620.HKD","IE00B1XK9C88.USD","CURE","LU0466842654.USD","LU2361045086.USD","LU1983299246.USD","IE0001KFT4U8.USD","ELIS","LU0266013472.USD","LU1267930730.SGD","LU0109391861.USD","LU1551013425.SGD","LU1974910355.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU0158827781.USD","TMED","LU0106261372.USD","LU0225283273.USD","LU2461242641.AUD","LU1868836757.USD","LU0417517546.SGD","LU0353189680.USD","LU1804176565.USD","LU1712237335.SGD","LU2023251221.USD","PJP","LU0133085943.USD","IYH","LU2462157665.USD","VHT","LU0210536198.USD","BK4534","LU2471134523.USD","LU0320765992.SGD","LU0061475181.USD","IE00BWXC8680.SGD","LU0238689110.USD","LU2111349929.HKD","LU1064131342.USD","LU0122379950.USD","IE00BJJMRY28.SGD","PPH","LU2896262040.SGD","LU0345770993.USD","LLYZ","ELIL","LU2756315664.SGD","LU2417539215.USD","LU0889565916.HKD","BK4533","LU0882574139.USD","IE00BFSS8Q28.SGD","LU2237443978.SGD","LU2552382215.SGD","IE00BN29S564.USD","LU0289739699.SGD","THNR","LU0672654240.SGD","CANC","XLV","LU0823434740.USD","LLY","LU1127390331.HKD","LU2168563687.JPY","IHE","LU0820562030.AUD","LU0203202063.USD","LU1023059063.AUD","IE0004445239.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU0471298777.SGD","MEDX","FHLC","LU0097036916.USD","LU0006306889.USD","LU0079474960.USD","LU0158827948.USD","LU1979441026.SGD","SGXZ31699556.SGD","LU2237443895.HKD","LU2462591350.SGD","LU2360106947.USD","LU0256863811.USD","LU1061106388.HKD","LLII","LU0943347566.SGD","LU2168564222.USD","LU2357305700.SGD","WDNA","LU0882574055.USD","IE00BJT1NW94.SGD","LU1232071149.USD","SG9999015952.SGD","SG9999014880.SGD","AGNG","BK4599","LU0353189763.USD","LU2468319806.SGD","LU1814569148.SGD","HRTS","RXL","LU2028103732.USD","LU1057294990.SGD","LU1551013342.USD","IE00B4JS1V06.HKD","LU2063271972.USD","LU2089283258.USD","SG9999014914.USD","LU2023250504.SGD","LU0354030438.USD","LU2237443622.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU1868837136.USD","LU2471134796.USD","BK4585","LU0256863902.USD","LU1623119135.USD","LU1868837300.USD","LU2750360641.GBP","LU0198837287.USD","BK4588","LU2552382132.HKD","IE0002141913.USD","IE0005OL40V9.USD","LU1989771016.USD","SGXZ57979304.SGD","SG9999015945.SGD","LU1868836914.USD","SGXZ99366536.SGD","LU1093756168.USD","LU1868836591.USD","OZEM","LU2756315318.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU0058720904.USD","ILDR","IXJ","LU1291159041.SGD","LU2361044865.SGD","LU1720051108.HKD","LU2168564149.EUR","TRUH","LU0823416689.USD","LU2106854487.HKD","IE00BKPKM429.USD","LU2324357040.USD","LU2602419157.SGD","SG9999015986.USD","LU0471298694.HKD","LU2746668974.SGD","SG9999017495.SGD","SG9999015978.USD","LU2552382058.USD","LU0787776722.HKD","LU1720051017.SGD","LU1323610961.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU0109394709.USD","LU0174119429.USD","LU1093756325.SGD","LU1988902786.USD","IE00BJJMRZ35.SGD","MHIP","SG9999001176.SGD","LU0786609619.USD","LU1917777945.USD","FTXH","SG9999001176.USD","LU0964807845.USD","SG9999018857.SGD","LU0823434583.USD","LLYX","LU2089984988.USD","LU2237443382.USD","LU2361044949.HKD","IE00B775H168.HKD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU1145028129.USD","IE00BFSS7M15.SGD","LU2264538146.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240445","title":"Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240445?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0432979614.USD","SG9999014914.USD","SG9999014906.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","LU2089283258.USD","LU2168564149.EUR","LU1551013342.USD","LU2360106947.USD","ILDR","IE0004445239.USD","LU1145028129.USD","BK4588","LU1061106388.HKD","LU0823434740.USD","TRUH","LU2361044949.HKD","LU0320765992.SGD","BK4585","CURE","LU2462591350.SGD","SG9999018865.SGD","LU2471134879.HKD","IE00BK4W5L77.USD","LU1720051017.SGD","BK4581","PJP","LU0689472784.USD","LU0456855351.SGD","LU2756315664.SGD","LU2746668461.USD","LU0094547139.USD","LU2028103732.USD","LU0471298694.HKD","LU1035775433.USD","LU2213496289.HKD","LLYZ","LU1868837136.USD","LU1868837300.USD","LU0234572021.USD","LU1989771016.USD","AGNG","LU2089984988.USD","LU0289739699.SGD","LU0640476718.USD","SG9999015952.SGD","LU2468319806.SGD","LU0471298777.SGD","LU2491050154.USD","LU2552382215.SGD","PPH","LU0061475181.USD","LU1804176565.USD","BK4533","LU2750360997.AUD","IE00BKPKM429.USD","LU2168564495.EUR","LLY","LU2896262040.SGD","IE00BJJMRY28.SGD","IE00BJT1NW94.SGD","SG9999001176.USD","LU2357305700.SGD","LU0820562030.AUD","IE00BJJMRX11.SGD","GB00BDT5M118.USD","IE00B1XK9C88.USD","LU0158827948.USD","LU1979441026.SGD","LU2112291526.USD","LU1691799644.USD","LU2462157665.USD","LU1069344957.HKD","LU0708995401.HKD","RXL","LU0345770993.USD","LU1323610961.USD","SG9999015978.USD","SGXZ99366536.SGD","LU1280957306.USD","LU2168564065.EUR","LU0114720955.EUR","FTXH","LU2168563687.JPY","LU0820561909.HKD","IE00B4JS1V06.HKD","LU1712237335.SGD","LU2361044865.SGD","LU2023251221.USD","IE0009355771.USD","LU2361045086.USD","SGXZ51526630.SGD","LU1267930730.SGD","BK4007","LLII","LU0203202063.USD","LU1023059063.AUD","LU1064131342.USD","LU1093756168.USD","IE0005OL40V9.USD","LU1551013425.SGD","VHT","LU0079474960.USD","LU2271345857.HKD","LU2111349929.HKD","LU0345770308.USD","LU2471134796.USD","IE00BFTCPJ56.SGD","LU2106854487.HKD","SG9999015945.SGD","LU0174119429.USD","LU2324357040.USD","LU0353189680.USD","LU1623119135.USD","SG9999018857.SGD","TMED","CANC","LU1868836591.USD","LU2602419157.SGD","BK4534","LU0158827781.USD","LU2087625088.SGD","LU2756315318.SGD","SG9999014898.SGD","SGXZ81514606.USD","LU2063271972.USD","XLV","LU0122379950.USD","LU0198837287.USD","IE00BFSS7M15.SGD","IE00B1BXHZ80.USD","LU0353189763.USD","LU0385154629.USD","LU1988902786.USD","LU2108987350.USD","LU2417539215.USD","LU0943347566.SGD","LU1366192091.USD","LU2236285917.USD","LU0820561818.USD","LU0266013472.USD","LU0823434583.USD","SG9999015986.USD","LU1232071149.USD","LU0683600562.USD","LU0889565916.HKD","MEDI","SG9999001176.SGD","BK4516","IE00BFSS8Q28.SGD","LU0058720904.USD","IE0004445015.USD","LU2750360641.GBP","MHIP","LU0882574055.USD","LU1814569148.SGD","LU1974910355.USD","LU0672654240.SGD","LU2237443465.HKD","LU2265009873.SGD","ELIS","LU0238689110.USD","WDNA","LU0466842654.USD","SG9999014880.SGD","JDOC","IE00BN29S564.USD","LU1868836914.USD","IE00BWXC8680.SGD","LU1127390331.HKD","SG9999013999.USD","ELIL","LU0210536198.USD","LU0354030511.USD","LU2471134952.CNY","IE00BK4W5M84.HKD","OZEM","LU2552382132.HKD","LU0882574139.USD","LU2471134523.USD","IE0001KFT4U8.USD","LU2264538146.SGD","LU2456880835.USD","LU1093756325.SGD","IE00B7KXQ091.USD","LU0109394709.USD","LU0320765059.SGD","LU1548497426.USD","LU0787776722.HKD","LU2237443622.USD","LU0256863902.USD","LU1629891620.HKD","IYH","LU2023250504.SGD","LU0964807845.USD","LU0109391861.USD","LU0096364046.USD","LLYX","LU0786609619.USD","LU2461242641.AUD","IE00B775H168.HKD","SG9999017495.SGD","IHE","LU2211815571.USD","IE0002141913.USD","LU2491049909.HKD","LU2491050071.SGD","SGXZ31699556.SGD","LU1720051108.HKD","IXJ","LU0225283273.USD","LU2237443549.SGD","SGXZ57979304.SGD","LU0354030438.USD","LU2023250330.USD","BK4599","LU1983299246.USD","LU0823416689.USD","LU2237438978.USD","MEDX","LU2168564222.USD","LU0106261372.USD","LU2552382058.USD","IE00BJLML261.HKD","LU0203201768.USD","LU0006306889.USD","LU1868836757.USD","LU2089284900.SGD","IE00BKDWB100.SGD","LU2746668974.SGD","LU1057294990.SGD","LU0316494557.USD","GDOC","LU2237443382.USD","IE00B4R5TH58.HKD","LU0133085943.USD","HRTS","LU0323591593.USD","THNR","LU1917777945.USD","LU0097036916.USD","LU2237443895.HKD","LU2237443978.SGD","FHLC","LU1291159041.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240410","title":"Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240410?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0266013472.USD","IE00BK4W5L77.USD","LU0106261372.USD","LU0354030438.USD","LU1623119135.USD","LU2089984988.USD","LU2213496289.HKD","ILDR","IHE","LU2237443978.SGD","BK4534","IE00BJT1NW94.SGD","MHIP","PPH","IE00BK4W5M84.HKD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2462157665.USD","LU0683600562.USD","LU2462591350.SGD","LU1691799644.USD","LU1720051108.HKD","ELIS","LU0234572021.USD","LU1868836591.USD","MEDX","LU0889565916.HKD","SGXZ51526630.SGD","LU2756315318.SGD","LU0174119429.USD","LU0320765992.SGD","LU2106854487.HKD","LU2361044949.HKD","LU0061475181.USD","CURE","IE00BKPKM429.USD","LLII","LU1814569148.SGD","SG9999015986.USD","IYH","LU0385154629.USD","LU0640476718.USD","LU2112291526.USD","SG9999014880.SGD","LU2089284900.SGD","IE00B7KXQ091.USD","SG9999018865.SGD","LU0122379950.USD","BK4533","LU0114720955.EUR","LU2211815571.USD","LU2089283258.USD","LLY","LU1804176565.USD","LU2491050071.SGD","OZEM","IE00B1BXHZ80.USD","LU2491049909.HKD","LU0353189763.USD","BK4588","LU0882574055.USD","LU1720051017.SGD","IE00BJJMRY28.SGD","LU0109391861.USD","IXJ","WDNA","LU0820561818.USD","LU2471134952.CNY","BK4599","LU1064131342.USD","LU1983299246.USD","LU2491050154.USD","LU2756315664.SGD","LU0256863902.USD","LU0672654240.SGD","LU0210536198.USD","LU1267930730.SGD","LU2471134796.USD","LU2552382058.USD","LU1868836757.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","LU1366192091.USD","LU0787776722.HKD","LU2168564065.EUR","LU1712237335.SGD","LU0323591593.USD","LU2602419157.SGD","LU0096364046.USD","LLYX","LU0289739699.SGD","LU0097036916.USD","LU0345770993.USD","LU0345770308.USD","LU0353189680.USD","LU0256863811.USD","LLYZ","LU1023059063.AUD","LU1093756325.SGD","LU0198837287.USD","BK4516","BK4585","LU0058720904.USD","LU0432979614.USD","LU2237443382.USD","SG9999001176.USD","LU2237443465.HKD","LU0689472784.USD","LU2471134523.USD","IE0004445015.USD","LU0823434740.USD","LU0823434583.USD","LU2111349929.HKD","LU2168564149.EUR","LU0238689110.USD","SGXZ99366536.SGD","LU0320765059.SGD","LU0964807845.USD","LU2237438978.USD","LU2746668461.USD","LU2552382215.SGD","CANC","LU0109394709.USD","IE00B2B36J28.USD","LU1323610961.USD","LU2361045086.USD","SGXZ81514606.USD","TMED","LU2023251221.USD","LU0820561909.HKD","SG9999014898.SGD","LU0417517546.SGD","VHT","LU2028103732.USD","AGNG","LU1061106388.HKD","SG9999001176.SGD","FHLC","TRUH","LU0158827948.USD","ELIL","LU0158827781.USD","LU2237443622.USD","LU1629891620.HKD","LU2108987350.USD","LU0943347566.SGD","LU2468319806.SGD","IE00BN29S564.USD","LU2271345857.HKD","LU2063271972.USD","LU2361044865.SGD","HRTS","SG9999015952.SGD","SG9999017495.SGD","IE00B1XK9C88.USD","SG9999014906.USD","SGXZ57979304.SGD","LU2461242641.AUD","LU2552382132.HKD","LU0316494557.USD","LU2023250504.SGD","IE00B4JS1V06.HKD","IE0002141913.USD","PJP","LU0471298694.HKD","LU1127390331.HKD","IE0009355771.USD","LU1280957306.USD","LU1035775433.USD","SG9999015978.USD","LU2023250330.USD","IE0001KFT4U8.USD","IE0005OL40V9.USD","GB00BDT5M118.USD","LU0456855351.SGD","LU0823416689.USD","LU1057294990.SGD","SG9999018857.SGD","LU1868836914.USD","LU1979441026.SGD","LU2746668974.SGD","LU1988902786.USD","LU1989771016.USD","IE00B775H168.HKD","GDOC","LU0471298777.SGD","LU1145028129.USD","LU1868837136.USD","XLV","LU1093756168.USD","SG9999014914.USD","LU2750360997.AUD","LU2168563687.JPY","LU1548497426.USD","LU0786609619.USD","IE0004445239.USD","LU1917777945.USD","LU0203202063.USD","LU0354030511.USD","LU1069344957.HKD","LU1291159041.SGD","LU0094547139.USD","LU2237443549.SGD","LU0882574139.USD","SG9999015945.SGD","LU2417539215.USD","LU2750360641.GBP","BK4581","LU0466842654.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU2087625088.SGD","LU2168564495.EUR","JDOC","LU2265009873.SGD","SG9999013999.USD","IE00BFSS7M15.SGD","BK4007","LU2324357040.USD","RXL","LU0079474960.USD","LU2360106947.USD","IE00BFSS8Q28.SGD","LU2896262040.SGD","IE00BKDWB100.SGD","LU0203201768.USD","LU0006306889.USD","LU2236285917.USD","LU0820562030.AUD","LU2471134879.HKD","IE00BWXC8680.SGD","LU1974910355.USD","LU0225283273.USD","THNR","LU1232071149.USD","LU2357305700.SGD","LU2237443895.HKD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0708995401.HKD","LU2264538146.SGD","FTXH","LU2168564222.USD","MEDI","LU0133085943.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240400","title":"Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240400?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0096364046.USD","MEDI","IE00BKDWB100.SGD","IE00BJLML261.HKD","LU0672654240.SGD","LU1551013425.SGD","HRTS","IE0004445239.USD","LU2461242641.AUD","LU0882574139.USD","LU2462591350.SGD","LU2271345857.HKD","LU1979441026.SGD","LU2213496289.HKD","LU0203202063.USD","LU0061475181.USD","LU1720051108.HKD","LU0471298694.HKD","LU0820561818.USD","LU1323610961.USD","LU0320765059.SGD","AGNG","LU2491049909.HKD","LU2746668974.SGD","LU1366192091.USD","LU1061106388.HKD","LU1551013342.USD","LU0079474960.USD","LU2236285917.USD","LU0823434740.USD","LU2237443622.USD","LU0109394709.USD","BK4585","LU0097036916.USD","LU2471134879.HKD","MHIP","LU1291159041.SGD","LU1057294990.SGD","LU1989771016.USD","LU2361044949.HKD","LU0320765992.SGD","LU1064131342.USD","IE00BJJMRX11.SGD","BK4581","LU2417539215.USD","LU2237443895.HKD","SG9999015945.SGD","LU1983299246.USD","LU0466842654.USD","IE00BKPKM429.USD","LU2112291526.USD","LU1267930730.SGD","IYH","RXL","LU0122379950.USD","LU0354030511.USD","FTXH","LU2168564495.EUR","IXJ","LU1691799644.USD","LU2750360641.GBP","IE00B1BXHZ80.USD","SG9999015986.USD","LU2896262040.SGD","PJP","IE00B4R5TH58.HKD","IE00BJJMRY28.SGD","LU0158827781.USD","LU0689472784.USD","LU2264538146.SGD","LU0385154629.USD","LU1623119135.USD","SG9999014898.SGD","LU0823434583.USD","LU0106261372.USD","IE0002141913.USD","LU2237438978.USD","SG9999014906.USD","SGXZ99366536.SGD","LU0432979614.USD","LU2756315318.SGD","CURE","VHT","IE00B1XK9C88.USD","LU0256863902.USD","TRUH","IE0009355771.USD","LU0708995401.HKD","LU0354030438.USD","JDOC","LLYX","BK4007","LU2265009873.SGD","LU2357305700.SGD","THNR","PPH","LU1127390331.HKD","LU2168564222.USD","LU0266013472.USD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU0109391861.USD","LU2361044865.SGD","BK4533","SG9999017495.SGD","LU2552382132.HKD","SGXZ31699556.SGD","SG9999018857.SGD","LU2168564065.EUR","LU0345770308.USD","IE00B7KXQ091.USD","LU0225283273.USD","BK4599","LU2746668461.USD","LU1712237335.SGD","LU0114720955.EUR","LU0889565916.HKD","LU1868837300.USD","LU2089283258.USD","IE0004445015.USD","LU0943347566.SGD","LU1093756325.SGD","LU2168563687.JPY","LU2324357040.USD","LU2471134952.CNY","IE00BFTCPJ56.SGD","LU0006306889.USD","XLV","LU1035775433.USD","LU1988902786.USD","LU0417517546.SGD","LLY","SGXZ57979304.SGD","LU2756315664.SGD","MEDX","BK4516","IE00BK4W5M84.HKD","LU0787776722.HKD","LU1093756168.USD","LU0158827948.USD","LU2491050071.SGD","LU2168564149.EUR","IE00BK4W5L77.USD","LU2106854487.HKD","LU2602419157.SGD","LU2063271972.USD","LU2456880835.USD","CANC","LU2471134523.USD","LU2750360997.AUD","LU1023059063.AUD","LU2108987350.USD","LU2462157665.USD","LU2491050154.USD","SG9999015978.USD","LU0640476718.USD","LU0823416689.USD","LU0353189763.USD","LU0471298777.SGD","LU2471134796.USD","BK4534","LU2089984988.USD","LU1280957306.USD","LU0683600562.USD","IE00BFSS7M15.SGD","LU0058720904.USD","LU1232071149.USD","LU0786609619.USD","LLYZ","LLII","LU2087625088.SGD","IE00BFSS8Q28.SGD","LU2111349929.HKD","LU2361045086.USD","ELIS","LU0210536198.USD","IE00B4JS1V06.HKD","LU0323591593.USD","IE0001KFT4U8.USD","BK4588","TMED","LU2237443978.SGD","LU1069344957.HKD","LU0238689110.USD","LU1868836591.USD","LU0133085943.USD","SGXZ81514606.USD","LU2468319806.SGD","WDNA","LU2023250504.SGD","SG9999013999.USD","LU0174119429.USD","LU0094547139.USD","GB00BDT5M118.USD","LU0203201768.USD","LU0316494557.USD","OZEM","LU2552382215.SGD","LU1720051017.SGD","LU1548497426.USD","IE00BWXC8680.SGD","LU0456855351.SGD","SG9999014914.USD","LU2211815571.USD","IE00BJT1NW94.SGD","ILDR","LU1145028129.USD","IHE","LU1814569148.SGD","LU2089284900.SGD","LU0198837287.USD","LU0820562030.AUD","SG9999001176.SGD","FHLC","LU2237443465.HKD","LU2360106947.USD","SGXZ51526630.SGD","LU1804176565.USD","IE0005OL40V9.USD","LU1629891620.HKD","LU2023250330.USD","LU0820561909.HKD","GDOC","LU2237443549.SGD","LU1868836757.USD","LU1917777945.USD","SG9999001176.USD","LU2028103732.USD","SG9999014880.SGD","LU1974910355.USD","LU0964807845.USD","SG9999018865.SGD","LU0234572021.USD","SG9999015952.SGD","IE00B2B36J28.USD","IE00B775H168.HKD","LU1868837136.USD","IE00BN29S564.USD","LU0353189680.USD","LU2552382058.USD","LU2237443382.USD","LU0345770993.USD","LU0256863811.USD","LU0289739699.SGD","LU2023251221.USD","ELIL","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671105312","title":"Roche's New Breast-Cancer Drug Supports Midterm Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2671105312","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671105312?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:50","pubTimestamp":1790689800,"startTime":"0","endTime":"0","summary":"1350 GMT - Roche Holding provided an encouraging update on its plans for a new breast-cancer drug, which together with other upcoming product launches underscore the company's confidence in its growth through the end of the decade, Citi analysts say. The Swiss drugmaker signaled it is comfortable with 2027 consensus estimates for sales of its breast-cancer drug, giredestrant, of 600 million Swiss francs, Citi says in a research note. Roche plans a patient-assistance program, offering the drug for free to some patients initially to reduce access barriers with the hope of seeing a \"hockey-stick\" launch trajectory, the analysts say. Citi expects the sales impact to be covered by 2028, and reiterates its forecast of annual peak sales of $14.5 billion. Shares fall 1.2%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Roche's New Breast-Cancer Drug Supports Midterm Growth Outlook","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","HRTS","RHHBY","03165","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671058217","title":"Roche Shows New Research-and-Development Approach is Bearing Fruit","url":"https://stock-news.laohu8.com/highlight/detail?id=2671058217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671058217?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:36","pubTimestamp":1790688960,"startTime":"0","endTime":"0","summary":"1336 GMT - Roche Holding's clinical-trial success rate has improved and research-and-development cycles shortened since the company introduced a more stringent approach to its drug pipeline after a series of failed studies in 2022, Vontobel's Stefan Schneider says. The Swiss drugmaker used an event with investors on Monday to showcase the progress it made over the past year, the analyst says in a research note. Even if Roche disclosed it is dropping development of muscle-sparing drug emugrobart for obesity, ten positive late-stage study results over the past year reassure about its future growth outlook, the analyst adds. \"Today, the company has an overall smaller number of pipeline projects ongoing, but they are more carefully selected when being pushed through the clinic to the market,\" Vontobel says. Shares fall 1.4%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","BK4007","CANC","HRTS","RHHBY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671339212","title":"Roche Dashes Hopes of Guidance Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2671339212","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671339212?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:55","pubTimestamp":1790686500,"startTime":"0","endTime":"0","summary":"1255 GMT - Roche Holding struck an upbeat tone on its drug pipeline, but didn't deliver the guidance upgrade some expected, as it gave investors an update on its pharma business, RBC Capital Markets analysts say in a research note. The Swiss pharma group said Monday that it plans new studies for its breast-cancer drug candidate giredestrant across different treatment lines, combinations and settings of the disease. \"While the breadth of the giredestrant program and broader pipeline provided encouragement around Roche's longer-term growth potential, the lack of midterm guidance update meant the event unlikely provided the incremental upside catalyst some investors had been hoping for,\" they add. Shares fall 1.2%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","HRTS","03165","BK4007","RHHBY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671925214","title":"Roche Needs Next Drug Launches to Go Smoothly","url":"https://stock-news.laohu8.com/highlight/detail?id=2671925214","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671925214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:35","pubTimestamp":1790685300,"startTime":"0","endTime":"0","summary":"1235 GMT - Roche Holding shares trade at a premium to those of peers, which will be difficult to justify if the launches of its next drugs don't deliver on expectations, Jefferies analysts say in a research note. There were no big surprises in the Swiss drugmaker's update on its pharma business held Monday and 2027 is shaping up to be a year more focused on regulatory filings than on clinical-trial results, the analysts say. \"What is now perhaps even clearer is that 2027 giredestrant and fenebrutinib launches must deliver, if approved, as key clinical catalysts don't emerge until closer to 2028,\" Jefferies says, referring to Roche's new drugs for breast cancer and multiple sclerosis, respectively. Shares fall 1.2%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","03165","BK4007","RHHBY","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671214345","title":"Roche Signals it is Too Soon to Know if AI Improves Trial Success Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2671214345","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671214345?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:22","pubTimestamp":1790684520,"startTime":"0","endTime":"0","summary":"1222 GMT - Roche Holding's research and early development is becoming more productive thanks to the integration of AI into its workflows, but it is too soon to know if the technology improves a drug candidate's chances in a clinical trial, J.P. Morgan analysts say in a research note. The Swiss drugmaker said it is using AI to speed up the process of discovering new medicines, and ultimately aims to improve the quality of those that it moves to the development phase. \"While they are making significant progress enhancing the research process, whether this will lead to enhanced probability of success will only become clear as the molecules go through clinical testing over the coming 3-5 years,\" the analysts say. Shares fall 1.4%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","HRTS","RHHBY","BK4007","CANC","CHAT","QTOC","AIPO","03165","VTHR","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671112292","title":"Roche Seems Increasingly Confident in Obesity Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2671112292","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671112292?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:13","pubTimestamp":1790683980,"startTime":"0","endTime":"0","summary":"1212 GMT - Roche Holding's confidence in its portfolio of medicines for obesity and diabetes seems to be growing as the Swiss drugmaker seeks an expansion into broader cardiovascular indications, UBS analysts say in a research note. \"Management continues to expect a highly segmented obesity market, with orals a critical pillar both as monotherapy and in combinations, and sees oral therapies expanding the market,\" the analysts say. Roche believes the glucose-control performance of its enicepatide drug candidate in a recent midstage trial warrants a head-to-head comparison study against Eli Lilly's Mounjaro in diabetes, with no decision yet on a similar study in obesity, they add. Moreover, the company plans to test enicepatide for cardiac conditions, while moving two other experimental obesity drugs to late-stage studies. Shares fall 1.1%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Roche Seems Increasingly Confident in Obesity Portfolio","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","03165","BK4007","RHHBY","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211626","title":"Eli Lilly Reports Zepbound Showed 4.5% Greater Weight Loss Than Novo Nordisk's Wegovy HD","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211626","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211626?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:02","pubTimestamp":1790683358,"startTime":"0","endTime":"0","summary":"Eli Lilly  said Tuesday that a new indirect analysis showed its drug Zepbound produced 4.5% greater weight loss than Novo Nordisk's  Wegovy HD in adults with obesity.The analysis compared data from the SURMOUNT-1 and STEP UP trials, according to the company.Patients taking a 15-milligram dose of Zepbound achieved the 4.5% greater average weight reduction over 72 weeks, the company said.Participants receiving a 10-milligram dose of the medication lost 3.2% more of their body weight on average compared with those on Wegovy HD, it said.Those taking the highest Zepbound dose were more than three times as likely to achieve at least a 20% reduction in body weight, and discontinuation rates due to adverse events were comparable across both treatments, Eli Lilly said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014906.USD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2023250330.USD","LU2456880835.USD","IE00BK4W5L77.USD","ELIL","LU2471134523.USD","MEDX","SGXZ81514606.USD","LU2168564222.USD","IXJ","LU0109391861.USD","LU1988902786.USD","HRTS","LU2471134952.CNY","LU2462157665.USD","LU2552382215.SGD","LU0133085943.USD","LU2271345857.HKD","TMED","LU1023059063.AUD","LU2468319806.SGD","BK4534","FHLC","LU1093756325.SGD","LU1280957306.USD","IYH","LU1868837136.USD","PPH","NVOX","LU2023251221.USD","LU0238689110.USD","LU0466842654.USD","LU2491050071.SGD","LU0456855351.SGD","LU0114720955.EUR","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1868836757.USD","LU2168563687.JPY","LU2552382058.USD","IE00BK4W5M84.HKD","LU0096364046.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU1979441026.SGD","LLII","OZEM","SG9999015986.USD","LU0787776722.HKD","LU2461242641.AUD","LU2108987350.USD","LU0006306889.USD","LU0345770308.USD","VHT","BK4585","IE00B775H168.HKD","LU1868836914.USD","LU1720051108.HKD","LU0820561909.HKD","LU0354030511.USD","IE00BJJMRX11.SGD","NVO","LU0174119429.USD","CURE","LU2112291526.USD","BK4599","LU1267930730.SGD","SG9999013999.USD","LU2237443978.SGD","LU0889565916.HKD","LU0106261372.USD","LU0210536198.USD","LU1623119135.USD","SGXZ57979304.SGD","LU0640476718.USD","LU1868836591.USD","LU2462591350.SGD","LU2896262040.SGD","RXL","LU2089283258.USD","BK4581","LU0353189763.USD","SG9999018865.SGD","LU0345770993.USD","LU0823434583.USD","LU1983299246.USD","LU1629891620.HKD","LU0158827948.USD","LU1974910355.USD","LU1064131342.USD","LU1145028129.USD","NVOC","LU0320765992.SGD","LU2361044949.HKD","IE00B7KXQ091.USD","LU2106854487.HKD","LU0672654240.SGD","LU2063271972.USD","IE00BZ1G4Q59.USD","LU1551013425.SGD","LU2756315318.SGD","LU0689472784.USD","LU1291159041.SGD","LU2602419157.SGD","IE00BJJMRZ35.SGD","ILDR","JDOC","SG9999001176.USD","LU2264538146.SGD","LU0823416689.USD","SG9999017495.SGD","IE0002141913.USD","SGXZ31699556.SGD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU0820562030.AUD","SG9999018857.SGD","IE00B4JS1V06.HKD","IHE","LU2168564495.EUR","LU2237443549.SGD","LU2471134879.HKD","LLYX","TRUH","LU1035775433.USD","LU2491049909.HKD","LU1232071149.USD","IE00BJT1NW94.SGD","LU2213496289.HKD","LU1804176565.USD","LU2491050154.USD","IE0005OL40V9.USD","IE00BN29S564.USD","LU2552382132.HKD","SGXZ51526630.SGD","GB00BDT5M118.USD","LU2360106947.USD","LU0122379950.USD","LU2746668461.USD","LU2361045086.USD","LU0432979614.USD","LU1551013342.USD","NVOH","LU0203202063.USD","LU0256863902.USD","LU0320765059.SGD","LU0061475181.USD","SG9999015952.SGD","LU2211815571.USD","SG9999014898.SGD","MHIP","IE00BKPKM429.USD","LU2750360641.GBP","LU1366192091.USD","LU2236285917.USD","IE00B1XK9C88.USD","LU0882574139.USD","LU1093756168.USD","LU0203201768.USD","LU0964807845.USD","LU2087625088.SGD","LU2237438978.USD","IE00B2B36J28.USD","AGNG","GDOC","LU1814569148.SGD","IE0004445015.USD","LU0385154629.USD","LU2237443622.USD","LU2237443465.HKD","LU0094547139.USD","LU1548497426.USD","LU0316494557.USD","WDNA","LU1712237335.SGD","LU2746668974.SGD","CANC","IE00BFTCPJ56.SGD","LU0786609619.USD","SG9999001176.SGD","LU0820561818.USD","LU1061106388.HKD","LU0417517546.SGD","LU0256863811.USD","BK4588","LU1069344957.HKD","LLYZ","LU2028103732.USD","SG9999015978.USD","LU1868837300.USD","LU2324357040.USD","LU2471134796.USD","IE00BKDWB100.SGD","LU0353189680.USD","IE0009355771.USD","IE00BJLML261.HKD","IE00BKVL7J92.USD","ELIS","LU0109394709.USD","LU2111349929.HKD","SG9999014914.USD","LU0079474960.USD","LU0708995401.HKD","MEDI","IE0004445239.USD","LU0154236417.USD","LU0158827781.USD","LU2756315664.SGD","PJP","BK4516","LU1917777945.USD","LU0058720904.USD","LU0225283273.USD","LU0323591593.USD","LU0683600562.USD","LU0289739699.SGD","LLY","LU0823434740.USD","XLV","LU0198837287.USD","LU2237443895.HKD","LU2237443382.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU1057294990.SGD","LU1127390331.HKD","BK4007","LU2361044865.SGD","LU0097036916.USD","LU1720051017.SGD","LU2023250504.SGD","LU0234572021.USD","LU2750360997.AUD","SG9999014880.SGD","THNR","LU1323610961.USD","LU0354030438.USD","LU2168564065.EUR","IE00B4R5TH58.HKD","BK4532","LU0471298777.SGD","LU1989771016.USD","LU2265009873.SGD","LU2357305700.SGD","LU0943347566.SGD","LU0882574055.USD","LU2089984988.USD","LU0266013472.USD","LU2417539215.USD","SGXZ99366536.SGD","BK4533","LU2089284900.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216297","title":"Eli Lilly’s Zepbound shows improved weight loss vs. Wegovy in new analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216297","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216297?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:11","pubTimestamp":1790680265,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) announced results from a new analysis showing that Zepbound – tirzepatide – 10 mg and 15 mg, a dual GIP and GLP-1 receptor agonist,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lillys-zepbound-shows-improved-weight-loss-vs-wegovy-in-new-analysis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lillys-zepbound-shows-improved-weight-loss-vs-wegovy-in-new-analysis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","LU0708995401.HKD","LU2087625088.SGD","GB00BDT5M118.USD","LU1712237335.SGD","LU0964807845.USD","LU1629891620.HKD","SGXZ57979304.SGD","LU1868837136.USD","SGXZ81514606.USD","LU0345770308.USD","SG9999001176.SGD","LU1291159041.SGD","LU2746668461.USD","LU0385154629.USD","MHIP","SG9999014906.USD","LU1804176565.USD","LU2471134879.HKD","LU2168563687.JPY","RXL","SGXZ31699556.SGD","IE00B775H168.HKD","LU0114720955.EUR","LU0471298694.HKD","LU2237443978.SGD","LU2324357040.USD","LU1093756325.SGD","LU2265009873.SGD","LU2417539215.USD","LU1548497426.USD","LU1064131342.USD","LU2361044865.SGD","BK4588","XLV","LU2108987350.USD","BK4516","LU0466842654.USD","LU2360106947.USD","LU0882574055.USD","PPH","PJP","LU1145028129.USD","IE0002141913.USD","LU2237443549.SGD","FTXH","LU0210536198.USD","LU2491049909.HKD","LU2756315664.SGD","IE00BKDWB100.SGD","LU2089284900.SGD","VHT","IE0009355771.USD","IE00BJJMRX11.SGD","IE00BK4W5M84.HKD","LU2023250504.SGD","LU0943347566.SGD","LU2213496289.HKD","LU2602419157.SGD","SG9999015945.SGD","BK4585","BK4581","LLY","SG9999014880.SGD","ELIS","LU0823416689.USD","LU1551013342.USD","SG9999013999.USD","GDOC","LLYX","LU0058720904.USD","IE00BJLML261.HKD","LU0471298777.SGD","LU2023251221.USD","BK4534","LU0109391861.USD","LU0456855351.SGD","LU1057294990.SGD","LU0109394709.USD","LU1061106388.HKD","LU2896262040.SGD","LU1868836591.USD","LU2491050154.USD","LU2361045086.USD","LU0417517546.SGD","LU0234572021.USD","LU0203202063.USD","LU0133085943.USD","LU0323591593.USD","LU2236285917.USD","LU1323610961.USD","MEDX","LU2168564222.USD","LU0106261372.USD","ILDR","IE0001KFT4U8.USD","LU1280957306.USD","LU2111349929.HKD","LU0097036916.USD","LU1979441026.SGD","LU1069344957.HKD","LU2237443382.USD","LU0096364046.USD","LU2750360997.AUD","LU1267930730.SGD","LU2089283258.USD","THNR","IE00BFTCPJ56.SGD","LU0266013472.USD","CURE","BK4533","IE00BFSS7M15.SGD","LU0320765059.SGD","LU0158827948.USD","LU0320765992.SGD","HRTS","LU1093756168.USD","TMED","LU2028103732.USD","LU2750360641.GBP","LU1127390331.HKD","LU0238689110.USD","LU2237443465.HKD","LU0354030438.USD","LU1720051017.SGD","LU0345770993.USD","IE0005OL40V9.USD","SG9999015952.SGD","LU1623119135.USD","LLII","LU2468319806.SGD","LU2471134523.USD","SGXZ99366536.SGD","LU1868837300.USD","LU1868836757.USD","LU2237438978.USD","LU2471134952.CNY","LU0289739699.SGD","LU0316494557.USD","MEDI","CANC","LU0158827781.USD","LU1974910355.USD","LU1988902786.USD","LU2756315318.SGD","IE00BWXC8680.SGD","LU0079474960.USD","LU2211815571.USD","LU0174119429.USD","LU1917777945.USD","SG9999015978.USD","SGXZ51526630.SGD","IE00B4JS1V06.HKD","IXJ","SG9999001176.USD","SG9999014914.USD","LU0823434583.USD","LU0889565916.HKD","LU2023250330.USD","LU0354030511.USD","LU0820562030.AUD","LU1814569148.SGD","LLYZ","IE00BJT1NW94.SGD","TRUH","LU2456880835.USD","AGNG","LU0689472784.USD","LU2746668974.SGD","LU1035775433.USD","LU0432979614.USD","SG9999014898.SGD","ELIL","IE00B2B36J28.USD","IE00BJJMRY28.SGD","LU0256863902.USD","LU1720051108.HKD","IE00BKPKM429.USD","IE00B1XK9C88.USD","IE00B1BXHZ80.USD","LU0672654240.SGD","SG9999015986.USD","LU2112291526.USD","LU2063271972.USD","LU2471134796.USD","IE00BK4W5L77.USD","IE00BJJMRZ35.SGD","LU0820561818.USD","IE00B4R5TH58.HKD","LU2271345857.HKD","LU2552382058.USD","LU0353189680.USD","LU0122379950.USD","LU0786609619.USD","LU1691799644.USD","IE0004445015.USD","BK4599","SG9999018865.SGD","LU0256863811.USD","LU2462591350.SGD","LU0823434740.USD","SG9999017495.SGD","LU2106854487.HKD","LU0820561909.HKD","LU2089984988.USD","IE00B7KXQ091.USD","LU0225283273.USD","IE00BFSS8Q28.SGD","LU0353189763.USD","LU0882574139.USD","LU1366192091.USD","LU1989771016.USD","LU2168564065.EUR","LU2168564495.EUR","LU0006306889.USD","LU2357305700.SGD","LU2461242641.AUD","IYH","LU2237443895.HKD","LU0787776722.HKD","LU2237443622.USD","IE0004445239.USD","LU1551013425.SGD","LU1868836914.USD","LU1232071149.USD","LU0640476718.USD","IHE","LU0203201768.USD","BK4007","LU0683600562.USD","LU2491050071.SGD","LU2552382215.SGD","OZEM","FHLC","LU0094547139.USD","LU1023059063.AUD","LU2552382132.HKD","LU0061475181.USD","LU1983299246.USD","LU2168564149.EUR","LU2264538146.SGD","LU2361044949.HKD","LU2462157665.USD","LU0198837287.USD","IE00BN29S564.USD","SG9999018857.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671735215","title":"Eli Lilly - Zepbound 10 Mg and 15 Mg Show Comparable Adverse Event Discontinuation Rates to Wegovy Hd","url":"https://stock-news.laohu8.com/highlight/detail?id=2671735215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671735215?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:00","pubTimestamp":1790679602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA7RLVWP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4JS1V06.HKD","LU2462591350.SGD","LU1548497426.USD","VHT","LU1035775433.USD","OZEM","SG9999018857.SGD","LU1629891620.HKD","BK4007","LU1057294990.SGD","ILDR","LU0096364046.USD","LU2461242641.AUD","LU0203201768.USD","LU1868836591.USD","LU1323610961.USD","IE00BN29S564.USD","MEDX","LU0417517546.SGD","LU1127390331.HKD","LU1917777945.USD","LU1974910355.USD","LU2237443465.HKD","LU1291159041.SGD","LU1023059063.AUD","LU1989771016.USD","LU0133085943.USD","LU0158827948.USD","LU2112291526.USD","LU2746668461.USD","IE0004445015.USD","LU0823434583.USD","LU1093756168.USD","LU2063271972.USD","LU0786609619.USD","LU2357305700.SGD","IE00BFSS7M15.SGD","PJP","LU0672654240.SGD","LU1804176565.USD","IE00B1XK9C88.USD","LU2746668974.SGD","LU0079474960.USD","LU0354030511.USD","IE0001KFT4U8.USD","LU2552382132.HKD","LU1280957306.USD","BK4533","JDOC","AGNG","LU1232071149.USD","IE00BFTCPJ56.SGD","LU0471298694.HKD","LU0823416689.USD","CURE","LLYX","LU0289739699.SGD","LU1988902786.USD","LU2750360641.GBP","WDNA","LU0238689110.USD","LU2265009873.SGD","LU0158827781.USD","LU1814569148.SGD","LU2108987350.USD","LU2023250504.SGD","LU2089283258.USD","LU2750360997.AUD","IE0002141913.USD","LU0109391861.USD","IE00B2B36J28.USD","GDOC","LU1093756325.SGD","IE00BK4W5M84.HKD","LU0122379950.USD","LU1267930730.SGD","LLII","BK4534","LU0061475181.USD","SG9999001176.SGD","BK4588","LU0266013472.USD","LU2237443382.USD","LU2168564495.EUR","LU0106261372.USD","LU2168563687.JPY","IE00BKPKM429.USD","LU2168564222.USD","SG9999017495.SGD","LU2491049909.HKD","IE0005OL40V9.USD","SG9999013999.USD","LU1064131342.USD","LLYZ","IE00BJJMRZ35.SGD","LU1366192091.USD","LU0316494557.USD","LU1691799644.USD","LU2111349929.HKD","LU2361045086.USD","IE00BJJMRX11.SGD","ELIS","TRUH","IE00B1BXHZ80.USD","LU1720051108.HKD","HRTS","LU2211815571.USD","LU0683600562.USD","LU0787776722.HKD","MEDI","LU2602419157.SGD","LU0354030438.USD","LU0708995401.HKD","LU2237443549.SGD","SG9999001176.USD","IE00BWXC8680.SGD","LU0820561909.HKD","BK4599","LU0210536198.USD","LU1551013342.USD","LU2106854487.HKD","LU1712237335.SGD","LU1868837136.USD","LU2271345857.HKD","LU2089984988.USD","LU2552382215.SGD","SG9999014898.SGD","LU2471134796.USD","IE00BJJMRY28.SGD","IE00BKDWB100.SGD","LU0471298777.SGD","LU1061106388.HKD","LU2324357040.USD","LU2237443978.SGD","LU2360106947.USD","FTXH","LU2213496289.HKD","LU0094547139.USD","LU2471134879.HKD","LU2361044949.HKD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2417539215.USD","LU0889565916.HKD","LU0820562030.AUD","LU0820561818.USD","CANC","GB00BDT5M118.USD","IE00B7KXQ091.USD","LU0256863811.USD","SG9999014914.USD","LU2023250330.USD","BK4581","BK4516","LU0345770308.USD","LU0345770993.USD","FHLC","LU0385154629.USD","LU0964807845.USD","LU1623119135.USD","LU0198837287.USD","LU0174119429.USD","LU0058720904.USD","IHE","IXJ","LU0466842654.USD","SGXZ31699556.SGD","XLV","LU1983299246.USD","THNR","LU2087625088.SGD","LU0320765059.SGD","LU1868836757.USD","LU2028103732.USD","LU2471134952.CNY","LU1145028129.USD","SG9999014906.USD","SG9999014880.SGD","IE00BK4W5L77.USD","LU0456855351.SGD","LU1868837300.USD","LU0882574055.USD","LLY","LU0823434740.USD","LU0323591593.USD","LU2361044865.SGD","LU2236285917.USD","LU2023251221.USD","SG9999015986.USD","RXL","LU2471134523.USD","SG9999018865.SGD","SGXZ57979304.SGD","MHIP","LU0203202063.USD","IE00BFSS8Q28.SGD","LU1069344957.HKD","LU2462157665.USD","IE00B4R5TH58.HKD","PPH","LU2468319806.SGD","IE0009355771.USD","LU2756315318.SGD","TMED","IE00BJT1NW94.SGD","LU0943347566.SGD","LU1720051017.SGD","LU0353189680.USD","LU2896262040.SGD","LU2756315664.SGD","LU0097036916.USD","LU1868836914.USD","LU0114720955.EUR","LU2264538146.SGD","SG9999015952.SGD","LU2491050071.SGD","ELIL","LU0353189763.USD","LU2168564065.EUR","IE00B775H168.HKD","LU0006306889.USD","LU2456880835.USD","LU2237438978.USD","SGXZ81514606.USD","LU0320765992.SGD","LU1551013425.SGD","LU2552382058.USD","LU2089284900.SGD","LU1979441026.SGD","SG9999015945.SGD","LU0109394709.USD","LU2491050154.USD","LU0256863902.USD","IE00BJLML261.HKD","IYH","SG9999015978.USD","IE0004445239.USD","LU2237443622.USD","LU2237443895.HKD","LU0225283273.USD","LU0432979614.USD","LU0234572021.USD","LU0882574139.USD","LU2168564149.EUR","BK4585","LU0640476718.USD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671621573","title":"Eli Lilly - Zepbound 15 Mg Shows 4.5% Greater Weight Loss than Wegovy Hd in Adults with Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671621573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671621573?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:00","pubTimestamp":1790679602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA7RLVWP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PJP","LU2491049909.HKD","LU2028103732.USD","LU0096364046.USD","LU0256863902.USD","LLY","SG9999018857.SGD","SGXZ51526630.SGD","GDOC","SG9999017495.SGD","BK4516","IYH","SGXZ81514606.USD","ELIS","LU1291159041.SGD","WDNA","LU0109394709.USD","LU2746668461.USD","IHE","LU1064131342.USD","LU0158827781.USD","LU0823434583.USD","MEDI","LU2471134879.HKD","LU0353189680.USD","IE0004445239.USD","LU2360106947.USD","LU2265009873.SGD","LU2471134523.USD","LU2552382132.HKD","LU2112291526.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","SG9999013999.USD","LU0943347566.SGD","BK4599","LU1267930730.SGD","IE00B1BXHZ80.USD","FHLC","LU0097036916.USD","LU1093756168.USD","LU1868837300.USD","LU0316494557.USD","LU2361044949.HKD","LU2237443382.USD","LU1720051017.SGD","LU0210536198.USD","SG9999001176.SGD","LU2896262040.SGD","SG9999015945.SGD","LLYX","LU1061106388.HKD","LU0106261372.USD","LU0234572021.USD","LU2361045086.USD","IE00B775H168.HKD","LLII","LU1551013425.SGD","LU2106854487.HKD","LU2237443895.HKD","LU2023250504.SGD","LU1232071149.USD","CANC","IE0009355771.USD","LU1629891620.HKD","LU1868836757.USD","LU1917777945.USD","LU2237443465.HKD","SG9999001176.USD","OZEM","SG9999014914.USD","LU0683600562.USD","LU0345770308.USD","LU2471134796.USD","LU0094547139.USD","LU2236285917.USD","IE0005OL40V9.USD","LU2468319806.SGD","LU0471298777.SGD","LU1814569148.SGD","LU0417517546.SGD","LU1983299246.USD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","IE0002141913.USD","LU1868836591.USD","SGXZ57979304.SGD","LU0823434740.USD","AGNG","IE00BN29S564.USD","THNR","BK4534","LU2023250330.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0354030511.USD","LU2237438978.USD","LU2111349929.HKD","LU0708995401.HKD","LU2462591350.SGD","LU2361044865.SGD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU2237443549.SGD","LU2237443978.SGD","LU2324357040.USD","LU2491050154.USD","VHT","LLYZ","LU0203202063.USD","LU0466842654.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1989771016.USD","LU1280957306.USD","LU0122379950.USD","LU1988902786.USD","SG9999018865.SGD","LU0225283273.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU0289739699.SGD","LU1623119135.USD","IE00BJJMRX11.SGD","LU2087625088.SGD","LU2108987350.USD","SGXZ31699556.SGD","SGXZ99366536.SGD","TMED","LU0174119429.USD","LU0320765059.SGD","LU0354030438.USD","HRTS","LU1366192091.USD","LU1145028129.USD","LU0889565916.HKD","SG9999014906.USD","LU1551013342.USD","LU2168564065.EUR","LU2213496289.HKD","LU0456855351.SGD","IE00B2B36J28.USD","LU2552382215.SGD","LU2461242641.AUD","LU1057294990.SGD","IE0004445015.USD","FTXH","LU0882574139.USD","TRUH","LU0256863811.USD","MEDX","LU2491050071.SGD","LU0823416689.USD","CURE","LU0640476718.USD","LU0198837287.USD","LU2750360641.GBP","XLV","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2462157665.USD","IXJ","IE00BKDWB100.SGD","LU1323610961.USD","IE00B4JS1V06.HKD","LU2089284900.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0158827948.USD","JDOC","LU1974910355.USD","LU0820561909.HKD","LU0006306889.USD","LU0079474960.USD","MHIP","LU0320765992.SGD","RXL","SG9999015952.SGD","LU2471134952.CNY","LU0109391861.USD","SG9999014898.SGD","LU1548497426.USD","LU1720051108.HKD","LU2357305700.SGD","LU2063271972.USD","LU0689472784.USD","LU0353189763.USD","LU1804176565.USD","LU1979441026.SGD","LU2168564222.USD","LU2552382058.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU2756315318.SGD","LU0786609619.USD","LU0471298694.HKD","LU0964807845.USD","LU0882574055.USD","LU0114720955.EUR","LU2089984988.USD","LU2756315664.SGD","LU0672654240.SGD","SG9999014880.SGD","LU1127390331.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1691799644.USD","LU2264538146.SGD","LU0266013472.USD","BK4581","LU0061475181.USD","LU2237443622.USD","LU2750360997.AUD","PPH","BK4007","IE00BKPKM429.USD","LU2023251221.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","ELIL","LU0820561818.USD","LU2089283258.USD","LU1093756325.SGD","BK4533","IE00BWXC8680.SGD","LU1023059063.AUD","LU1035775433.USD","LU1868836914.USD","SG9999015986.USD","LU2271345857.HKD","LU2746668974.SGD","LU0385154629.USD","ILDR","LU0058720904.USD","LU0820562030.AUD","LU0133085943.USD","LU0238689110.USD","IE0001KFT4U8.USD","IE00BJLML261.HKD","LU1868837136.USD","LU2168564149.EUR","BK4588","LU2602419157.SGD","LU2456880835.USD","BK4585","LU0787776722.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}